Table 2 Characteristics of group with an increase in frailty score from baseline to 12 months, compared to those with no change or a decrease in score (n = 120).
Increase in frailty score (n = 52) | Decreased or stable frailty score (n = 68) | p-value | |
|---|---|---|---|
Age at dialysis start (years); median (IQR) | 67.5 (51.5–74.5) | 74 (67–80) | p < 0.0011 |
Male sex; n (%) | 37 (71.2) | 47 (69.1) | p = 0.8092 |
Dialysis modality; n (%) | |||
Haemodialysis | 37 (71.2) | 48 (70.6) | p = 0.9462 |
Peritoneal dialysis | 15 (28.9) | 20 (29.4) | |
Charlson-comorbidity score; mean (SD) | 3.7 (1.4) | 4.2 (1.5) | p = 0.0513 |
Comorbidities; n (%) | |||
Diabetes mellitus | 29 (55.8) | 47 (69.1) | p = 0.1332 |
Ischaemic heart disease/ left ventricular failure | 12 (23.1) | 23 (33.8) | p = 0.1992 |
Stroke/ TIA | 5 (9.6) | 9 (13.2) | p = 0.5402 |
Peripheral arterial disease | 3 (5.8) | 5 (7.5) | p = 0.730 |
